Immune Response of Elderly Individuals to a Live Attenuated Varicella Vaccine

Journal of Infectious Diseases

Volumn 166, Issue 2, 1992, Pages 253-259

  Levin, Myron J ^a,b,c   Murray, Martha ^a,b,c   Rotbart, Harley A ^a,b,c   Zerbe, Gary O ^a,b,c   Jo White, C ^a,b,c   Hayward, Anthony R ^a,b,c  

^a Wyeth Lederle Vaccines   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; LIVE VACCINE; VARICELLA ZOSTER VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHICKENPOX VACCINE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG TOLERANCE; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; MALE; MIDDLE AGE; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0026696802     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/166.2.253     Document Type: Article

References (44)

1. Straus SE, Ostrove JE, Inchauspé G, et al. Varicella-zoster virus infections: biology, natural history, treatment, and prevention. Ann Intern Med 1988;108:221-37.
2. Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 1983;2:814-6.
3. Gilden DH, Vafai A, Shtram Y, Becker Y, Devlin M, Wellish M. Varicella-zoster virus DNA in human sensory ganglia. Nature 1983;306:478-80.
4. Croen KD, Ostrove JM, Dragovic LJ, Straus SE. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 1988;85:9773-7.
5. Mahalingham R, Wellish M, William W. et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990;323:627-31.
6. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-21.
7. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP. Perry HO. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310-6.
8. de Moragas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Dermatol 1957;75:193-6.
9. Rogers RS III. Tindall JP. Geriatric herpes zoster. J Am Geriatr Soc 1971;19:495-504.
10. Watson CPN. Postherpetic neuralgia. Neurol Clin 1989;7:231-48. 11. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989;39:129-44.
11. Miller AE. Selective decline in cellular immune response to varicellazoster in the elderly. Neurology 1980;30:582-7.
12. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 1981;32:24-7.
13. Burke BL, Steele RW, Beard OW. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982;142:291-3.
14. Hayward AR, Herberger M. Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol 1987;7:174-8.
15. Hayward A, Levin M, Wolf W, Angelova G. Varicella-zoster virus-specific immunity after herpes zoster. J Infect Dis 1991;163:873-5.
16. Feldman S, Hughes WT, Kim HY. Herpes zoster in children with cancer. Am J Dis Child 1973;126:178-84.
17. Dolin R, Reichman RC, Mazur MH, Whitley RJ. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 1978;89:375-88.
18. Melbye M. Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster. Lancet 1987;1:728-31.
19. Asano Y, Nagai T, Miyata T. Long-term protective immunity of recipients of the Oka strain of a live varicella vaccine. Pediatrics 1985;75:667-71.
20. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine; efficacy trial in healthy children. N Engl J Med 1984; 310:1409-15.
21. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78(suppl):748-56.
22. Gershon AA, Steinberg SP, LaRussa P, et al. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132-7.
23. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (Varivax) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
24. Berger R. Luescher D, Just M. Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine. J Infect Dis 1984; 149:647.
25. Berger R, Amstutz I, Just M, Just V, Luescher D. Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response. Antiviral Res 1985;1(suppl):267-71.
26. Henry C, Marbrook J, Vann DC, Kodlin D, Wojsy C. Limiting dilution analysis. In: Mishell BB, Shiigi SM, eds. Selected methods in cellular immunology. San Francisco: Freeman Press, 1980:138-45.
27. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982;38:963-74.
28. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986;42:805-20.
29. Nelder JA. Inverse polynomials, a useful group of multi-factor response functions. Biometrics 1966;22:128-41.
30. Hirst K, Zerbe GO, Boyle DW, Wilkening RB. On nonlinear random effects models for repeated measurements. Commun Stat 1991;20: 463-78.
31. Beverley PCL. Human T-cell memory. Curr Top Microbiol Immunol 1990;159:111-2.
32. Hayward A, Giller R, Levin M. Phenotype, cytotoxic and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immunol 1989;2:175-84.
33. Gershon AA, Steinberg SP. Antibody responses to varicella-zoster virus and the role of antibody in host defense. Am J Med Sci 1981;282:12-7.
34. Hayward AR. Herberger M. Saunders D. Herpes simplex virus-stimulated 7-interferon production by newborn mononuclear cells. Pediatr Res 1986;20:398-401.
35. Leibson PJ, Hunter-Laslow M, Hayward AR. Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J Virol 1986;57:976-82.
36. Goodwin JS. Searles RP. Tung KS. Immunological responses of healthy elderly population. Clin Exp Immunol 1982;48:403-10.
37. Tice RR, Schneider EL, Kram D, Thorne P. Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin. J Exp Med 1979; 149:1029-41.
38. Murasko DM. Nelson BJ, Silver S, Matour D, Kaye D. Immunologic response in an elderly population with a mean age of 85. Am J Med 1986;81:612-8.
39. Nagel JE, Chrest FJ, Adler WH. Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol 1981;127:2086-8.
40. Thompson JS, Wekstein DR, Rhoades JL, et al. The immune status of healthy centenarians. J Am Geriatr Soc 1984;32:274-81.
41. Staiano-Coico L, Darzynkiewicz Z, Melamed MR. Weksler ME. Immunological studies of aging. IX. Impaired proliferation of T lymphocytes detected in elderly humans by flow cytometiy. J Immunol 1984;132:1788-92.
42. Sohnle PG, Collins Lech C, Huhta KE. Age-related effects on the number of human lymphocytes in culture initially responding to an antigenic stimulus. Clin Exp Immunol 1982;47:138-46.
43. Dutkowski RT. Lesh R, Staiano-Coico L, Thaler H, Darlington GJ, Weksler ME. Increased chromosomal instability in lymphocytes from elderly humans. Mutat Res 1985;149:505-12.
44. Chopra RK, Holbrook NJ, Powers DC, McCoy MT. Adler WH, Nagel JE. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopathol 1989;53:297-308.